Results 121 to 130 of about 13,427 (242)

Immunological mechanisms of allergen-specific immunotherapy.

open access: yesAllergy, 2011
The studies on the mechanisms of specific immunotherapy (SIT) point out its targets that decide on the efficacy of SIT and hence might be used for its further improvement. Several mechanisms have been proposed to explain the beneficial effects of immunotherapy.
Jutel M, Akdis CA
openaire   +3 more sources

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy. [PDF]

open access: yesHeliyon, 2023
Reithofer M   +5 more
europepmc   +1 more source

Algorithms in Allergy: General Allergen Molecule‐Based Algorithm for Allergen‐Specific Immunotherapy

open access: yes
Allergy, EarlyView.
Huey‐Jy Huang   +6 more
wiley   +1 more source

Effectiveness and Predictors of House Dust Mite Subcutaneous Immunotherapy in Polysensitised Patients With Allergic Rhinitis: A Multicentre Retrospective Study

open access: yesClinical &Experimental Allergy, EarlyView.
Single‐allergen dust mite subcutaneous immunotherapy achieved 68.8% perennial symptom response rate in polysensitised allergic rhinitis patients. High mould and dust mite sIgE levels predicted poor allergen immunotherapy response, which indicated allergen‐specific sIgE levels may help guide personalised allergen immunotherapy decisions.
Zhouxian Pan   +13 more
wiley   +1 more source

Next-Generation Allergen-Specific Immunotherapy for Food Allergy. [PDF]

open access: yesClin Rev Allergy Immunol
Lee JZX   +6 more
europepmc   +1 more source

Safety of allergen-specific immunotherapy in children. [PDF]

open access: yesPediatr Allergy Immunol, 2022
De Filippo M   +11 more
europepmc   +1 more source

AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes

open access: yesClinical &Experimental Allergy, EarlyView.
ABSTRACT The AllergoOncology field brings together the study of allergic and cancer immune responses, having evolved from early epidemiological studies that reported inverse associations between allergies, IgE and cancer risk. Insights from studying allergic inflammation are revealing previously unappreciated immune mechanisms that confer protective ...
Jakub Zydron   +13 more
wiley   +1 more source

Patient‐Derived IgG Epitope Mapping of Bet v 1 Reveals Hypoallergenic Peptide Candidates for Safe and Next‐Generation Allergen Immunotherapy

open access: yesClinical &Experimental Allergy, EarlyView.
Mapping IgG epitopes of the major birch allergen Bet v 1 identified patient‐derived, hypoallergenic peptides that did not trigger degranulation. These findings support a novel, safer approach for peptide‐based allergen immunotherapy that leverages naturally induced IgG specificities from allergic individuals. ABSTRACT Background Allergen immunotherapy (
Lara Šošić   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy